Enveric Biosciences

ENVBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.356 M

$1.42 -3.40%

Close of 6 Nov 2026

As of 6 Nov 2026, Enveric Biosciences (ENVB) has a market capitalization of $6.36M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

$12.1M

#1996 by earnings

Shares outstanding

4,475,884

Latest filing cover page

P/E ratio

0.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#439Kiora PharmaceuticalsKPRX$6.64M
#440FibroBiologicsFBLG$6.36M
#441Enveric BiosciencesENVB$6.36M
#442CNS PharmaceuticalsCNSP$6.01M
#443ExicureXCUR$5.83M

What if Enveric Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$6,308,670

Per share 4,442,725× higher

Bitcoin $1.53T

$341,351.15

Per share 240,388× higher

Apple $5.02T

$1,120,624

Per share 789,172× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Enveric Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.